• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The time has come for next-generation sequencing in routine diagnostic workup in hematology.

作者信息

Haferlach Torsten

机构信息

MLL Munich Leukemia Laboratory, Munich.

出版信息

Haematologica. 2021 Mar 1;106(3):659-661. doi: 10.3324/haematol.2020.270504.

DOI:10.3324/haematol.2020.270504
PMID:33645944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7927880/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71f0/7927880/aad58e7c3e7f/106659.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71f0/7927880/aad58e7c3e7f/106659.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71f0/7927880/aad58e7c3e7f/106659.fig1.jpg

相似文献

1
The time has come for next-generation sequencing in routine diagnostic workup in hematology.在血液学常规诊断检查中，开展下一代测序的时机已经成熟。
Haematologica. 2021 Mar 1;106(3):659-661. doi: 10.3324/haematol.2020.270504.
2
The Value of Next-Generation Sequencing in the Screening and Evaluation of Hematologic Neoplasms in Clinical Practice.在临床实践中，下一代测序在血液系统肿瘤的筛查和评估中的价值。
Am J Clin Pathol. 2020 Apr 15;153(5):639-645. doi: 10.1093/ajcp/aqz203.
3
Philadelphia-Negative Myeloproliferative Neoplasms: Laboratory Workup in the Era of Next-Generation Sequencing.费城阴性骨髓增殖性肿瘤：下一代测序时代的实验室检测。
Curr Hematol Malig Rep. 2019 Oct;14(5):376-385. doi: 10.1007/s11899-019-00534-8.
4
Next-Generation Sequencing in Myeloproliferative Neoplasms: Is This Indicated in All Patients?下一代测序在骨髓增殖性肿瘤中的应用：所有患者都需要进行吗？
Curr Hematol Malig Rep. 2019 Jun;14(3):137-144. doi: 10.1007/s11899-019-00514-y.
5
Benefits of molecular profiling with next-generation sequencing for the diagnosis and prognosis of myeloproliferative neoplasms in splanchnic vein thrombosis.二代测序分子谱分析在脾静脉血栓形成的骨髓增殖性肿瘤诊断和预后中的应用价值
J Hepatol. 2021 Jan;74(1):251-252. doi: 10.1016/j.jhep.2020.07.043. Epub 2020 Sep 26.
6
Next-generation sequencing-based panel testing for myeloid neoplasms.基于二代测序的髓系肿瘤基因检测 panel 检测
Curr Hematol Malig Rep. 2015 Jun;10(2):104-11. doi: 10.1007/s11899-015-0256-3.
7
Next-generation sequencing discriminates myelodysplastic/myeloproliferative neoplasms from paraneoplastic leukemoid reaction in cancer patients with hyperleukocytosis.新一代测序可区分癌症患者高白细胞血症中骨髓增生异常/骨髓增殖性肿瘤与副肿瘤性类白血病反应。
Leuk Lymphoma. 2018 Jul;59(7):1742-1745. doi: 10.1080/10428194.2017.1397669. Epub 2017 Nov 8.
8
Molecular genetic biomarkers in myeloid malignancies.髓系恶性肿瘤中的分子遗传生物标志物。
Arch Pathol Lab Med. 2015 May;139(5):594-601. doi: 10.5858/arpa.2014-0096-RA. Epub 2014 Aug 25.
9
Conventional cytogenetics for myeloid neoplasms in the era of next-generation-sequencing.下一代测序时代髓系肿瘤的传统细胞遗传学
Am J Hematol. 2017 Mar;92(3):227-229. doi: 10.1002/ajh.24642.
10
[Implementing next-generation sequencing for precision hematology/oncology].[实施用于精准血液学/肿瘤学的下一代测序技术]
Rinsho Ketsueki. 2018;59(10):1924-1934. doi: 10.11406/rinketsu.59.1924.

引用本文的文献

1
Application of Next-Generation Sequencing-Based Mutational Profiling in Acute Lymphoblastic Leukemia.基于新一代测序的突变分析在急性淋巴细胞白血病中的应用。
Curr Hematol Malig Rep. 2021 Oct;16(5):394-404. doi: 10.1007/s11899-021-00641-5. Epub 2021 Oct 6.

本文引用的文献

1
WGS and WTS in leukaemia: A tool for diagnostics?白血病中的 WGS 和 WTS：诊断工具？
Best Pract Res Clin Haematol. 2020 Sep;33(3):101190. doi: 10.1016/j.beha.2020.101190. Epub 2020 Jun 5.
2
Machine learning in haematological malignancies.血液系统恶性肿瘤中的机器学习
Lancet Haematol. 2020 Jul;7(7):e541-e550. doi: 10.1016/S2352-3026(20)30121-6.
3
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms.成人骨髓增生异常/骨髓增殖性肿瘤的分子特征和克隆结构。
Blood. 2020 Oct 15;136(16):1851-1862. doi: 10.1182/blood.2019004229.
4
Diagnosis and prognosis are supported by integrated assessment of next-generation sequencing in chronic myeloid malignancies. A real-life study.基于二代测序的综合评估在慢性髓系肿瘤中的诊断和预后价值：一项真实世界研究。
Haematologica. 2021 Mar 1;106(3):701-707. doi: 10.3324/haematol.2019.242677.
5
Systematic benchmarking of omics computational tools.系统生物学计算工具的基准测试。
Nat Commun. 2019 Mar 27;10(1):1393. doi: 10.1038/s41467-019-09406-4.
6
Clonal Hematopoiesis with Oncogenic Potential (CHOP): Separation from CHIP and Roads to AML.具有致癌潜能的克隆性造血（CHOP）：与 CHIP 的分离及通向 AML 的道路。
Int J Mol Sci. 2019 Feb 12;20(3):789. doi: 10.3390/ijms20030789.
7
Molecular patterns in cytopenia patients with or without evidence of myeloid neoplasm-a comparison of 756 cases.有或无髓系肿瘤证据的血细胞减少症患者的分子模式——756例病例比较
Leukemia. 2018 Oct;32(10):2295-2298. doi: 10.1038/s41375-018-0119-8. Epub 2018 Mar 30.
8
Mutations in myeloproliferative neoplasms - their significance and clinical use.骨髓增殖性肿瘤中的突变——其意义及临床应用
Expert Rev Hematol. 2017 Nov;10(11):961-973. doi: 10.1080/17474086.2017.1380515. Epub 2017 Sep 25.
9
Clinical significance of somatic mutation in unexplained blood cytopenia.不明原因血细胞减少症中体细胞突变的临床意义。
Blood. 2017 Jun 22;129(25):3371-3378. doi: 10.1182/blood-2017-01-763425. Epub 2017 Apr 19.
10
Guidelines for Validation of Next-Generation Sequencing-Based Oncology Panels: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists.基于新一代测序的肿瘤学检测板验证指南：分子病理学协会和美国病理学家学会联合共识推荐
J Mol Diagn. 2017 May;19(3):341-365. doi: 10.1016/j.jmoldx.2017.01.011. Epub 2017 Mar 21.